Dublin, June 06, 2022 (GLOBE NEWSWIRE) -- The "Additive Technology Markets for Engineered Solid Dosage Forms" report has been added to ResearchAndMarkets.com's offering.

3D printing (3DP) or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees of complexity with great reproducibility, in a fast and cost-effective fashion.

3D printing has been used extensively in tissue and organ engineering, diagnostics, disease modelling, manufacturing of biomedical devices and the design and development of novel dosage forms. It is utilized in the pharmaceutical industries as a process innovation technology to construct digitally controlled and personalized products by converting a concept into a prototype additive manufacturing using 3D computer-aided design (CAD) or a Magnetic Resonance Image (MRI).

Key Questions Answered in the Additive Technology Markets for Engineered Solid Dosage Forms Report:

Key Topics Covered:

Executive Summary

3D Printing Architectures

3D Printing - Enabling Technologies

3D Printing Opportunities in Drug Customization

Market and Commercial Landscape

Market Drivers

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/w2myrf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.